Stoke Therapeutics Inc (NASDAQ:STOK) traded at $9.71 at close of the session on current trade day and made a downward move of -9.08% on its previous day’s price. Stoke Therapeutics Inc has a market cap of $514.31 million and is expected to release its quarterly
Stoke Therapeutics Inc (NASDAQ:STOK) price on Wednesday, February 05, rose 0.79% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $12.70. A look at the stock’s price movement, the close in the last trading session was $12.60, moving
Stoke Therapeutics Inc (NASDAQ:STOK) price closed higher on Monday, February 03, and jumping 0.35% above its previous close. A look at the daily price movement shows that the last close reads $11.48, with intraday deals fluctuated between $11.03 and $11.81. The company’s 5Y monthly beta
Stoke Therapeutics Inc (NASDAQ:STOK) price closed lower on Monday, January 13, and dropping -0.89% below its previous close. A look at the daily price movement shows that the last close reads $9.00, with intraday deals fluctuated between $8.57 and $9.0. The company’s 5Y monthly beta
Stoke Therapeutics Inc (NASDAQ:STOK) at last check was buoying at $8.92 on current market day with a fall of -0.44% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $8.96 and 5Y
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
